REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH MULTIPLE MYELOMA IN DIFFERENT GEOGRAPHICAL REGIONS: FINDINGS FROM A SYSTEMATIC LITERATURE REVIEW

EHA Library, Elena Zamagni, 324346

PARATHYROID HORMONE LEVELS AND PROGNOSIS IN MULTIPLE MYELOMA?

EHA Library, Joanna Su Ling Tung, 324347

DEMOGRAPHIC, CLINICAL, AND PROGNOSTIC CHARACTERISTICS OF PRIMARY PLASMA CELL LEUKEMIA IN LATIN AMERICA, A STUDY OF GELAMM GROUP.

EHA Library, Macarena Roa, 324348

DEVELOPING A MULTI-MODULE E-HEALTH APPLICATION FOR PATIENTS WITH MULTIPLE MYELOMA RECEIVING COMPLICATED TREATMENT REGIMENS.

EHA Library, Paul Geerts, 324349

IMMUNOPHENOTYPIC PROFILE AND CLINICAL CHARACTERISTICS OF PRIMARY AND SECONDARY PLASMA CELL LEUKEMIA

EHA Library, Renata Bezdekova, 324350

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 324351

PREVALENCE OF THROMBOTIC EVENTS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IMIDS.

EHA Library, Pablo Tenorio, 324352

RENAL IMPAIRMENT IN MULTIPLE MYELOMA: CHARACTERISTICS AND OUTCOMES OF 55 MOROCCAN PATIENTS

EHA Library, Mahtat EL MEHDI, 324353

FIRST-LINE TREATMENT OF OLDER PATIENTS WITH MULTIPLE MYELOMA (MM) WITH BORTEZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (VCD)

EHA Library, Konstantinos Liapis, 324354

SKELETAL RELATED EVENTS IN MULTIPLE MYELOMA: A RETROSPECTIVE SINGLE CENTRE ANALYSIS

EHA Library, Daniel Farrugia, 324355

FREQUENCY AND PROGNOSTIC SIGNIFICANCE OF MEDITERRANEAN FEVER GENE MUTATIONS IN MULTIPLE MYELOMA AND OTHER PLASMA CELL NEOPLASMS

EHA Library, Isik Kaygusuz Atagunduz, 324356

DARATUMUMAB IN TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA – EXPERIENCES OF THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES (KROHEM)

EHA Library, Josip Batinić, 324357

LENALIDOMIDE VERSUS THALIDOMIDE OR BORTEZOMIB AS MAINTENANCE REGIMEN FOR NON-TRANSPLANT PATIENTS WITH MULTIPLE MYELOMA: MULTI-CENTER REAL WORLD EXPERIENCES IN CHINA

EHA Library, Junling Zhuang, 324358

CONVENTIONAL CYTOGENETIC ANALYSIS IN PATIENTS WITH MULTIPLE MYELOMA – SINGLE CENTER STUDY

EHA Library, Radi Lukanov, 324359

COMPARISON OF 140MG/M2 VS 200MG/M2 DOSE OF MELPHALAN IN MYELOMA AUTOGRAFT – A SINGLE CENTER EXPERIENCE FROM CHENNAI, INDIA.

EHA Library, Kishore Kumar, 324360

CLINICAL OUTCOMES OF IXAZOMIB-BASED REGIMENS IN CHINESE PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY RECEIVING BORTEZOMIB-BASED INDUCTION REGIMEN: PROTOCOL FOR MODIFY STUDY

EHA Library, Wenming Chen, 324361

CLINICAL CHARACTERISTICS AND OUTCOMES, OF REFRACTORY OR RELAPSED MULTIPLE MYELOMA PATIENTS TREATED WITH ANTI-CD38 MONOCLONAL ANTIBODIES

EHA Library, Irene Zamanillo, 324362

THERAPEUTIC RESULTS OF BORTEZOMIB MULTIPLE MYELOMA TREATMENT: A MONOCENTRIC STUDY

EHA Library, Faten kallel, 324363

VCD VERSUS VRD‐BASED REGIMENS AS INDUCTION THERAPIES IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA (MM): UPDATED UKRAINIAN RETROSPECTIVE MULTICENTER ANALYSIS

EHA Library, Olga Novosad, 324364

THE HIGH-RISK CYTOGENETIC (HRC) INFLUENCES IN THE OUTCOME OF THE NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM).

EHA Library, María Irene Nuevo López, 324365

REAL‐LIFE OUTCOMES OF DARATUMUMAB TREATMENT IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA: EXPERIENCE FROM A SMALL PERIPHERAL HOSPITAL

EHA Library, D. Rochate, 324366

REAL WORLD TWO-CENTER EXPERIENCE OF DARATUMUMAB MONOTHERAPY IN HEAVILY PRETREATED RELAPSED/ REFRACTORY MULTIPLE MYELOMA

EHA Library, IRENE SANCHEZ PRIETO, 324367

POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 324368

FOUR PATIENTS DIAGNOSED OF AL AMYLOIDOSIS WITH SEVERE ORGAN DAMAGE WHO UNDERWENT AN AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOLLOWING AN INDUCTION TREATMENT: EXPERIENCE IN A THIRD LEVEL HOSPITAL

EHA Library, Natalia Alba, 324369

REAL WORLD EVIDENCE OF CARFILZOMIB IN RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, VASILIKI DOUKA, 324370

DREAMM-5 PLATFORM TRIAL: BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH FIVE DIFFERENT NOVEL AGENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, PAUL RICHARDSON, 324371

A RAPID RESPONSE WITH DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE COMBINATION IN A PATIENT WITH CASTLEMAN VARIANT OF POEMS SYNDROME

EHA Library, Yaşa Gül Mutlu, 324372

SCREENING OF SOMATIC MUTATIONS IN THE CALR GENE BY HIGH-RESOLUTION MELTING CURVE ANALYSIS

EHA Library, Dmitrij Kurochkin, 324373

SYSTEMIC MASTOCYTOSIS: A RETROSPECTIVE STUDY OF A SINGLE-CENTER’S EXPERIENCE ON A RARE DISEASE

EHA Library, Catarina Campos-Costa, 324374

EFFICACY AND SAFETY OF LUSPATERCEPT VERSUS PLACEBO IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED MYELOFIBROSIS ON JAK2 INHIBITOR THERAPY AND REQUIRING RBC TRANSFUSIONS (INDEPENDENCE TRIAL)

EHA Library, Ruben Mesa, 324375

THE FREQUENCY OF CD34+ CELLS PER CD45+ CELLS IN PERIPHERAL BLOOD ENUMERATED BY AUTOMATED METHOD IS EFFECTIVE AS A NON-INVASIVE MARKER OF MYELOFIBROSIS IN THE PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Takaaki Maekawa, 324376

CLINICAL BENEFIT IN REAL LIVE OF ALTERNATIVE RUXOLITINIB DOSING REGIME IN MYELOFIBROSIS PATIENTS

EHA Library, Francisca Hernandez Mohedo, 324377

REAL-LIFE RUXOLITINIB EXPERIENCE IN AN INTERMEDIATE-1 RISK PREDOMINANT COHORT

EHA Library, Tayfur Toptas, 324378

BIOEQUIVALENCE OF 50 MG ONCE-DAILY RUXOLITINIB EXTENDED RELEASE (XR) TABLETS COMPARED TO 25 MG TWICE-DAILY RUXOLITINIB IMMEDIATE RELEASE (IR) TABLETS

EHA Library, Xiaohua Gong, 324379

ESSENTIAL THROMBOCYTHEMIA AND THE RISK OF POLYPHARMACY: ASSESSMENT OF POTENTIAL DRUG-DRUG AND FOOD-DRUG INTERACTIONS

EHA Library, Mihnea-Alexandru Găman, 324380

LYMPHOPENIA IS HIGHLY PREVALENT IN OVERT MYELOFIBROSIS AT DIAGNOSIS AND ASSOCIATED WITH THE DEGREE OF ANEMIA AND THROMBOCYTOPENIA.

EHA Library, Tobias Silzle, 324381

SAFETY AND PHARMACOKINETICS OF BLU-263, A NEXT GENERATION KIT INHIBITOR, IN NORMAL HEALTHY VOLUNTEERS

EHA Library, Nimita Dave, 324382

GENERAL CHARACTERISTICS AND OUTCOME OF RENAL EXTRAMEDULLARY HEMATOPOIESIS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS-A LITERATURE REVIEW

EHA Library, Shehab Mohamed, 324383

PACIFICA: A RANDOMIZED, CONTROLLED PHASE 3 STUDY OF PACRITINIB VERSUS PHYSICIAN'S CHOICE IN PATIENTS WITH PRIMARY OR SECONDARY MYELOFIBROSIS AND SEVERE THROMBOCYTOPENIA

EHA Library, John Mascarenhas, 324384

A PHASE 1 STUDY OF TP-3654, AN ORAL PIM KINASE INHIBITOR, IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK PRIMARY OR SECONDARY MYELOFIBROSIS

EHA Library, Claudia Lebedinsky, 324385

A PHASE 1/2 STUDY OF INCB000928 AS MONOTHERAPY OR IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS (INCB 00928-104)

EHA Library, Stephen Oh, 324386

A TWO-PART PHASE 2 STUDY OF ITACITINIB IMMEDIATE RELEASE IN PATIENTS WITH PRIMARY OR SECONDARY MYELOFIBROSIS WHO HAVE RECEIVED PRIOR RUXOLITINIB AND/OR FEDRATINIB MONOTHERAPY

EHA Library, Andrew Kuykendall, 324387

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF ADD-ON PARSACLISIB IN PATIENTS WITH MYELOFIBROSIS WHO HAVE SUBOPTIMAL RESPONSE TO RUXOLITINIB

EHA Library, Abdulraheem Yacoub, 324388

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RUXOLITINIB PLUS PARSACLISIB IN PATIENTS WITH JAK- AND PI3K-INHIBITOR TREATMENT–NAÏVE MYELOFIBROSIS

EHA Library, Abdulraheem Yacoub, 324389

RELATIVE BIOAVAILABILITY AND DOSE LINEARITY OF FIVE STRENGTHS OF RUXOLITINIB EXTENDED RELEASE (XR) TABLETS

EHA Library, Xiaohua Gong, 324390

TUBERCULOSIS REACTIVATION FOLLOWING RUXOLITINIB THERAPY FOR MYELOFIBROSIS

EHA Library, Anil aribandi, 324391

A CASE OF POLYCYTHAEMIA VERA TREATED WITH ROPEGINTERFERON-2B DURING PREGNANCY

EHA Library, IRENE SANCHEZ PRIETO, 324392

A PHASE 1 STUDY OF INCB057643 MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (INCB 57643-103)

EHA Library, Justin M. Watts, 324393

CONSECUTIVE OCCURRENCE OF ACUTE MYELOID LEUKEMIA, CHRONIC LYMPHOCYTIC LEUKEMIA AND POLYCYTHEMIA VERA; EMERGENCE OF DRIVER MUTATIONS IN A CONTEXT OF CLONAL HEMOPOIESIS OF INDETERMINATE POTENTIAL.

EHA Library, VASILIKI DOUKA, 324394

ESSENTIAL THROMBOCYTEMIA IN THE YOUNG PATIENT: EXPERIENCE OF A SECONDARY HOSPITAL

EHA Library, Maria Remedios Arcas Vega, 324395

ADORE: A RANDOMIZED, OPEN-LABEL, PHASE 1/2 OPEN-PLATFORM STUDY EVALUATING SAFETY AND EFFICACY OF NOVEL RUXOLITINIB COMBINATIONS IN PATIENTS WITH MYELOFIBROSIS

EHA Library, David Ross, 324396

CLINICAL CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PH NEGATIVE MYELOPROLIFERATIVE NEOPLASMS TREATED IN A REFERRAL HOSPITAL IN MEXICO CITY

EHA Library, Gilberto Israel Barranco Lampón, 324397

SUCCESSFUL PREGNANCY OUTCOME IN ESSENTIAL THROMBOCYTAEMIA PATIENT AFTER MULTIPLE MISCARRIAGES WITH PLT NORMALISATION INDUCED BY GESTATIONAL THROMBOCYTOPENIA

EHA Library, Ines Vaide, 324398

MYELOFIBROSIS TREATMENT WITH RUXOLITINIB IN CLINICAL PRACTICE: AN ANALYSIS OF EFFICACY AND SAFETY OF A SINGLE CENTER

EHA Library, Rebeca Brito, 324399

RUXOLITINIB TREATMENT IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS (MPD) – A UNICENTER STUDY.

EHA Library, Vanessa Pereira, 324400

CHARACTERIZATION OF ADULTS SERIES OF MASTOCYTOSIS CASES IN A HEALTH CARE CENTER IN CALI

EHA Library, Jose Leonel Zambrano Urbano, 324401

OVERVIEW OF IMMUNE THROMBOCYTOPENIA MANAGEMENT IN CHILDREN, A SINGLE INSTITUTE EXPERIENCE

EHA Library, Hasanein Ghali, 324402

DENTOALVEOLAR PROCEDURES IN IMMUNE THROMBOCYTOPENIA; SYSTEMATIC REVIEW AND PRACTICAL RECOMMENDATIONS

EHA Library, Wobke E. M. van Dijk, 324403

CLINICAL AND BIOLOGICAL PREDICTORS OF CHRONICITY OF IMMUNE THROMBOCYTOPENIA IN ADULTS

EHA Library, Manel Bchir, 324404

NOT YET TO BE BORN – A CLINICAL CASE OF PSEUDOTHROMBOCYTOPENIA IN A PREGNANT WOMAN

EHA Library, Ana Catarina Marques, 324405

PHASE III MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RILZABRUTINIB, ORAL BTK INHIBITOR, IN ADULTS AND ADOLESCENTS WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, David Kuter, 324406

REVISION OVER 15 YEARS EXPERIENCE OF MULTIPLE AUTOINMUNE CYTOPENIAS IN HEMATOLOGICAL AND NON-HEMATOLOGICAL DISORDERS

EHA Library, Paula Melero Valentín, 324407

HEALTH-RELATED QUALITY OF LIFE AMONG REFRACTORY/RELAPSED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH KTE-X19: PHASE 2 RESULTS FROM ZUMA-3 TRIAL

EHA Library, Caitlyn Solem, 324408

PSYCHOLOGICAL DISTRESS IN OUTPATIENTS WITH LYMPHOMA DURING THE COVID-19 PANDEMIC

EHA Library, Carla Minoia, 324409

REAL-WORLD COSTS OF FRONT-LINE TREATMENT FOR PERIPHERAL T-CELL LYMPHOMA IN FRANCE, GERMANY, AND THE UNITED KINGDOM

EHA Library, Ajibade Ashaye, 324410

DETERMINING SATISFACTION WITH INTERPERSONAL RELATIONSHIP WITH NAVIGATOR MEASURE AMONG CAREGIVERS OF FILIPINO CHILDREN WITH CANCER IN A TERTIARY REFERRAL CENTER: A PATIENT NAVIGATION RESEARCH STUDY

EHA Library, Trixy Chu, 324411

DANISH PATIENTS WITH MULTIPLE MYELOMA REPORT NO CHANGE IN QUALITY OF LIFE DURING THE COVID-19 PANDEMIC

EHA Library, Louise Redder, 324412

DISPARITIES IN ACCESS TO HOSPITAL-AT-HOME FACILITIES FOR MULTIPLE MYELOMA PATIENTS TREATED AS OUTPATIENTS WITH INJECTABLE CHEMOTHERAPY IN FRANCE – A NATIONAL HOSPITAL DISCHARGE DATABASE STUDY.

EHA Library, Ulysse Rodts, 324413

EXPERIENCES AND SUPPORT NEEDS OF CAREGIVERS OF PATIENTS WITH HIGHER-RISK MDS: QUALITATIVE INSIGHTS VIA ONLINE BULLETIN BOARD IN THE US, UK, AND CANADA

EHA Library, Pauline Frank, 324414

‘A DIFFERENT PERSON ENTIRELY’: ADOLESCENT AND YOUNG ADULTS’ EXPERIENCES RETURNING TO EDUCATION AFTER TREATMENT FOR HAEMATOLOGICAL MALIGNANCIES

EHA Library, Cameron Magrath, 324415

SPIRITUALITY AND ITS INFLUENCE IN QUALITY OF LIFE IN HEMATOLOGICAL PATIENTS: A SYSTEMATIC REVIEW

EHA Library, Carolina Barbosa Carvalho Do Carmo, 324416

EFFECTS OF ISOLATION DURING THE COVID-19 PANDEMIC ON TEENAGERS WITH SICKLE CELL DISEASE IN ITALY: THE EXPERIENCE OF A DEDICATED TELEPHONE SERVICE FOR PSYCHOLOGICAL SUPPORT

EHA Library, Raffaella Colombatti, 324417

USE OF THE EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE MULTIPLE MYELOMA QUESTIONNAIRE (EORTC QLQ-MY20): A REVIEW OF THE LITERATURE 25 YEARS AFTER DEVELOPMENT.

EHA Library, Charalampia Kyriakou, 324418

INPATIENT CARE OF PATIENTS WITH EARLY-RELAPSED DIFFUSE B-CELL LYMPHOMA (DLBCL): AN ECONOMIC PERSPECTIVE

EHA Library, Bernhard Moertl, 324419

HEALTH –RELATED QUALITY OF LIFE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Manel Bchir, 324420

COST-EFFECTIVENESS OF RUXOLITINIB FOR PATIENTS WITH MYELOFIBROSIS: A REVIEW OF THE LITERATURE

EHA Library, Gizem Karakuleli, 324421

THAI-VERSION OF THE MD ANDERSON SYMPTOMS INVENTORY FORACUTE MYELOID LEUKEMIA/ MYELODYSPLASTIC SYNDROME (MDASI-AML/MDS): THE PSYCHOMETRIC PROPERTIES INVESTIGATION IN ADULT AML PATIENTS

EHA Library, Thanawat Rattanathammethee, 324422

ECO-HEALTH LITERACY ASSOCIATED WITH LEUKEMIA AMONG TUNISIAN YOUTHS AND PROSPECTS FOR EMPOWERMENT

EHA Library, Foued Maaoui, 324423

UNCERTAINTY ABOUT THE FUTURE: INSIGHTS FROM OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) ON DIFFERENT TREATMENT PATHS

EHA Library, Roland B. Walter, 324424

MEASURING HEALTH RELATED QUALITY OF LIFE OF CHRONIC MYELOID LEUKEMIA PATIENTS ON NEWER GENERATION TKIS USING THE FILIPINO VERSION OF THE FACT-LEU QUESTIONNAIRE

EHA Library, Camille Ariadne Tanchanco, 324425

NATIONAL REGISTRY-BASED SURVEILLANCE ON HEMOGLOBINOPATHIES IN TURKEY

EHA Library, Yesim Aydinok, 324426

PRIORITISATION OF RELEVANT COCHRANE REVIEW TOPICS IN THE FIELD OF HAEMATOLOGY

EHA Library, Caroline Hirsch, 324427

ENHANCING THE ACCESS OF COAGULATION FACTORS TO PATIENTS WITH HAEMOPHILIA IN ESTONIA

EHA Library, Ines Vaide, 324428

A PRECEDE - PROCEED MODEL APPROACH IN ESTABLISHING A HEMOPHILIA CENTER IN A TERTIARY MEDICAL INSTITUTION: A DESCRIPTIVE STUDY.

EHA Library, Paula Bianca Nuqui, 324429

THE IMPACT OF COVID-19 ON PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: THE MIXED-METHOD ANALYSIS OF AN ISRAELI NATIONAL SURVEY

EHA Library, Ilana Levy, 324430

THE PHARMACOKINETIC PROFILE OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Denis Soulières, 324431

GBT1118, A VOXELOTOR ANALOG PROTECTS RED CELLS FROM POLYMERIZATION-INDUCED DAMAGE DURING SEVERE HYPOXIA

EHA Library, Michael Tarasev, 324432

IMPACT OF SICKLE CELL DISEASE ON DAILY LIFE IN PATIENTS MANAGING VASO-OCCLUSIVE CRISES AT HOME VS THE EMERGENCY ROOM/HOSPITAL: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)

EHA Library, Erfan Nur, 324433

IMPACT OF COVID-19 ON SICKLE CELL DISEASE IN LEBANON; MILD DISEASE AND ONE CASE OF DEEP VEIN THROMBOSIS.

EHA Library, Noura El Hariri, 324434

HIBISCUS, AN ADAPTIVE, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF ORAL FT-4202, A PYRUVATE KINASE ACTIVATOR IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Kenneth Ataga, 324435

ECOCARDIOGRAPHIC EVALUATION OF CARDIOVASCULAR COMPLICATIONS IN PEDIATRIC SICKLE CELL DISEASE PATIENTS: MORE THAN MEETS THE EYE?

EHA Library, Giulia Ceglie, 324436

THE GREATALYS (GENERATING REAL WORLD EVIDENCE ACROSS ITALY IN SCD): EPIDEMIOLOGY AND DISEASE BURDEN IN ITALY

EHA Library, Carina Andrea Fiocchi, 324437

IN SICKLE CELL DISEASE WITH CHRONIC RETINAL COMPLICATION CAN HAEMATOLOGICAL PARAMETERS BE USEFUL AS A STRATIFYING RISK TOOL?

EHA Library, Christopher Saunders, 324438

CLINICAL CHARACTERISTICS AND THE RISK OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Spiros Tzivelekis, 324439

PEDIATRIC PATIENT REPORTED OUTCOMES IN PATIENTS RECEIVING VOXELOTOR FOR SICKLE CELL DISEASE

EHA Library, Clark Brown, 324440

CARDIAC INVOLVEMENT IN SICKLE Β-THALASSEMIA PATIENTS BY MAGNETIC RESONANCE IMAGING

EHA Library, Antonella Meloni, 324441

PANCREATIC IRON IS A MARKER OF CARDIOVASCULAR COMPLICATIONS AND IN SICKLE CELL DISEASE

EHA Library, Antonella Meloni, 324442

EFFECT OF HYDROXYUREA ON ADHESION MOLECULES IN YOUNG PATIENTS WITH SICKLE CELL BETA THALASSEMIA

EHA Library, Aikaterini Teli, 324443

EPIDEMIOLOGICAL CHARACTERS OF ADULTEGYPTIAN SICKLE CELL ANEMIA PATIENTS: A SINGLE CENTEREXPERIENCE

EHA Library, Mohamed Elbogdady, 324444

THE RELATIONSHIP OF SERUM GROWTH DIFFERENTIATING FACTOR 15(GDF15) TO HEPCIDIN IN POST TRANSPLANT ADULT EGYPTIAN PATIENTS AND ITS PROGNOSTIC SIGNIFICANCE

EHA Library, Mohamed Azzazi, 324445